Trial Profile
A retrospective study of Eslicarbazepine acetate in patients with focal seizures
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Mar 2016
Price :
$35
*
At a glance
- Drugs Eslicarbazepine acetate (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Acronyms ESLIBASE
- 25 Sep 2015 New trial record